HLB Co., Ltd.
028300
Rangering i aksjer
#3945
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Aksjekurs
$31.23
Markedsverdi
$4.15B
Endring (1 dag)
6.65%
Endring (1 år)
1.14%
Land
KR
Handel HLB Co., Ltd. (028300)
Kategori
Healthcare
Inntekter for HLB Co., Ltd. (028300)
Inntekter i Jun 2026 TTM: $67.40M
Ifølge de nyeste økonomiske rapportene til HLB Co., Ltd. er selskapets nåværende inntekter (TTM) $67.40M. I 2023 hadde selskapet inntekter på $33.14M en nedgang sammenlignet med inntektene i 2022, som var $142.41M. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for HLB Co., Ltd. fra 2012 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $67.40M | 45.45% |
| 2024 | $46.34M | 39.83% |
| 2023 | $33.14M | -76.73% |
| 2022 | $142.41M | 142.47% |
| 2021 | $58.73M | 13.50% |
| 2020 | $51.75M | 55.52% |
| 2019 | $33.27M | 2.38% |
| 2018 | $32.50M | 50.54% |
| 2017 | $21.59M | -13.64% |
| 2016 | $25.00M | -23.62% |
| 2015 | $32.73M | -3.69% |
| 2014 | $33.98M | 71.94% |
| 2013 | $19.76M | -59.26% |
| 2012 | $48.51M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $12.62B | 18,631.01% |
US
|
|
| $2.23B | 3,205.74% |
US
|
|
| $15.74B | 23,260.28% |
AU
|
|
| $6.02B | 8,833.94% |
NL
|
|
| - | - |
CH
|
